|
|
|
| |
|
|
| |
Business Week
March 17, 2008
Dr. Reddy's Mode of Discovery
The Indian drugmaker's CEO explains the company's move from generic offerings, and its intent on securing a spot among the world's top 25 pharma companies.
|
|
| |
|
|
| |
Bio Spectrum
March, 2008
Top 20 Life Sciences Institutes of India
Being the most cost effective and compliant contract manufacturing hub (for pharmaceuticals) in Asia, Indian CMO's are now becoming more innovative, diversified and are adopting state-of-the-art process technology and international standards to stay competitive.
|
|
| |
|
|
| |
Business Today
March, 2008
Meet Anji Reddy, The Philanthropist
The Chairman of Dr. Reddy's Labs is morphing into one of India's most committed givers. Dr. Reddy's eponymous founder in now attacking social problems.
|
|
| |
|
|
| |
Bio Spectrum
March, 2008
Dr. Reddy's aims to be a Biosimilar leader
Hyderabad-based, Dr. Reddy's Laboratories, the $1.2 billion Indian Pharma major, and one of the world's leading generics players, is making determined efforts to increase its portfolio of biosimilar products and become a global leader in the next decade in this space. A spacial report from the company's Hyderabad campus.
|
|
| |
|
|
| |
Outlook - Profit
March, 2008
There are plenty of opportunities in emerging markets
Dr. Reddy's Laboratories' COO and MD Satish Reddy lays out his plans to take one of India's biggest pharmaceutical companies to the next level of growth.
|
|
| |
|
|
| |
Global Logistics & Supply Chain Strategies
February, 2008
Generic Drug Manufacturer's Supply Chain Ills
Triple-digit growth rates, regulatory issues and the highly competitive nature of the generic drug market posed complexity issues for this India-based pharmaceutical company. UPS Supply Chain Solutions helped Dr. Reddy's sort it all out.
|
|
| |
|
|
| |
Business Today
January 27, 2008
Trials by Fire
Pharma entrepreneurs like Ajay Piramal and Anji Reddy are betting on drug discovery to double the industry's value to $129 billion by 2015.
|
|
| |
|
